Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2004 | 07-2003 | 07-2002 | 07-2001 | 07-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,232 | 3,844 | 6,923 | 6,813 | 6,625 |
| Depreciation Amortization | 2,362 | 1,808 | 2,154 | 2,252 | 1,925 |
| Income taxes - deferred | -1,651 | -128 | 720 | 2,003 | 255 |
| Accounts receivable | -12,880 | -6,344 | -9,897 | -16,347 | -16,498 |
| Accounts payable and accrued liabilities | 771 | N/A | N/A | N/A | N/A |
| Other Working Capital | -12,099 | -2,810 | -14,529 | -17,244 | -15,850 |
| Other Operating Activity | 24,147 | 15,737 | 24,187 | 30,520 | 28,474 |
| Operating Cash Flow | $-5,582 | $12,106 | $9,558 | $7,997 | $4,932 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,349 | -15,293 | N/A | N/A | N/A |
| PPE Investments | -1,304 | -957 | -620 | -1,014 | -791 |
| Purchase Sale Intangibles | -444 | -354 | -491 | -568 | -458 |
| Other Investing Activity | -444 | -354 | -505 | -573 | -458 |
| Investing Cash Flow | $-4,097 | $-16,604 | $-1,126 | $-1,587 | $-1,249 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 896 | 631 | 128 | 1,234 | 4,126 |
| Dividend Paid | N/A | N/A | -97 | N/A | N/A |
| Other Financing Activity | 14 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $910 | $631 | $31 | $1,234 | $4,126 |
| Beginning Cash Position | 63,268 | 67,135 | 58,671 | 51,027 | 43,218 |
| End Cash Position | 54,499 | 63,268 | 67,135 | 58,671 | 51,027 |
| Net Cash Flow | $-8,769 | $-3,867 | $8,464 | $7,644 | $7,809 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,582 | 12,106 | 9,558 | 7,997 | 4,932 |
| Capital Expenditure | -1,304 | -957 | -620 | -1,014 | -791 |
| Free Cash Flow | -6,886 | 11,149 | 8,938 | 6,983 | 4,141 |